Showing results (1261-1270 of 6,507) with videos related to
Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Autologous antibodies to human bladder cancerH B Grossman, G Wedemeyer, J SteinCancer Immunology, Immunotherapy : CII|April 19, 2021
Combined vaccine-immune-checkpoint inhibition constitutes a promising strategy for treatment of dMMR tumorsInken Salewski, Steffen Kuntoff, Andreas Kuemmel, et al.Cancer Immunology, Immunotherapy : CII|September 4, 2012
Human mucin MUC1 RNA undergoes different types of alternative splicing resulting in multiple isoformsLixin Zhang, Anda Vlad, Christine Milcarek, et al.Cancer Immunology, Immunotherapy : CII|September 4, 2012
MGN-3 arabinoxylan rice bran modulates innate immunity in multiple myeloma patientsDana Cholujova, Jana Jakubikova, Branislav Czako, et al.Cancer Immunology, Immunotherapy : CII|August 26, 2020
Immunogenic necroptosis in the anti-tumor photodynamic action of BAM-SiPc, a silicon(IV) phthalocyanine-based photosensitizerYing Zhang, Ying-Kit Cheung, Dennis K P Ng, et al.Cancer Immunology, Immunotherapy : CII|August 7, 2020
Expression pattern, regulation, and clinical significance of TOX in breast cancerMohit Arora, Sarita Kumari, Jay Singh, et al.Cancer Immunology, Immunotherapy : CII|August 7, 2020
A high number of PD-L1+ CD14+ monocytes in peripheral blood is correlated with shorter survival in patients receiving immune checkpoint inhibitorsKiyohiro Ando, Kazuyuki Hamada, Midori Shida, et al.Cancer Immunology, Immunotherapy : CII|August 18, 2020
The impact of ICOS+ regulatory T cells and Helicobacter pylori infection on the prognosis of patients with gastric and colorectal cancer: potential prognostic benefit of pre-operative eradication therapyShinya Urakawa, Makoto Yamasaki, Tomoki Makino, et al.Cancer Immunology, Immunotherapy : CII|August 5, 1998
Colon cancer cell vaccine prepared with replication-deficient vaccinia viruses encoding B7.1 and interleukin-2 induce antitumor response in syngeneic miceM Sivanandham, P Shaw, S F Bernik, et al.Cancer Immunology, Immunotherapy : CII|March 31, 2015
A combined approach of human leukocyte antigen ligandomics and immunogenicity analysis to improve peptide-based cancer immunotherapyJanet Kerstin Peper, Stefan StevanovićPageof 651